gms | German Medical Science

62. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Polnischen Gesellschaft für Neurochirurgen (PNCH)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

07. - 11. Mai 2011, Hamburg

Lectures Wednesday, 11 May 2011
MI.05 Tumor, Molecular Markers

Meeting Abstract (MI.05.02)

IDH mutations and their role in the progression of low grade gliomas

Juratli T, Robel K, Schackert G, Krex D
[Volltext]
Meeting Abstract (MI.05.03)

Unfavourable prognostic influence of IDH1 mutations in WHO Grade II astrocytomas turns into favourable predictive impact after malignant transformation

Thon N, Eigenbrod S, Kreth S, Lutz J, Tonn JC, Kretzschmar H, Peraud A, Kreth FW
[Volltext]
Meeting Abstract (MI.05.04)

The expression of MGMT and Ku80 in primary central nervous system lymphoma and their prognostic relevance

Dörner L, Li X, Mo W, Hugo HH, Kriesen T, Mehdorn HM
[Volltext]
Meeting Abstract (MI.05.05)

Intratumoral variation of MGMT promoter methylation in glioblastoma – a regional quantitative analysis

Dörner L, Hattermann K, Nabavi A, Malkus-Coskun U, Mehdorn HM, Held-Feindt J
[Volltext]
Meeting Abstract (MI.05.06)

Chromosome 7p11.2(EFFR) and 7q36.1(XRCC2) variants influence glioma risk

Simon M, Hosking FJ, Shete S, Zelenika D, Marie Y, Gousias K, Wichmann HE, Hemminki K, Lathrop M, Bondy M, Houlston RS, Sanson M
[Volltext]
Meeting Abstract (MI.05.07)

Epigenetic DNA methylation analysis as a diagnostic tool for brain tumors

Barciszewska AM, Nowak S, Gawronska I, Barciszewska MZ
[Volltext]
Meeting Abstract (MI.05.08)

Synergistic antiproliferative action of HER1/EGFR, RAC1 and SMO inhibition in erlotinib-sensitive human glioblastoma multiforme cells

Halatsch ME, Wirtz CR, Karpel-Massler G
[Volltext]
Meeting Abstract (MI.05.09)

Targeting the prognostic marker ALDH1 overcomes temozolomide resistance in human glioblastoma patients with unfavourable MGMT status

Ringel F, Schäfer A, Teufel J, Gempt J, Ryang YM, Pape H, Meyer B, Schlegel J
[Volltext]
Meeting Abstract (MI.05.10)

Risk factors for recurrence and malignant transformation of low grade astrocytomas

Juratli T, Robel K, Schackert G, Krex D
[Volltext]
Meeting Abstract (MI.05.11)

Membrane bound Hsp70 expression in gliomas: a novel, hypoxia-related marker for progression

Thorsteinsdottir J, Fu P, Guo K, Gehrmann M, Multhoff G, Schichor C
[Volltext]
Meeting Abstract (MI.05.12)

Expression of human endogenous retrovirus K (HERV-K) in human astrocytic tumors

Kessler AF, Hagemann C, Wiesner M, Denner J, Vince GH, Ernestus RI
[Volltext]